Freeline to present at the 3rd Annual Evercore ISI Health CONx Conference

Published 19 Nov 2020

Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy company with the ambition of transforming the lives of patients suffering from inherited systemic debilitating diseases, today announced that management will participate in a fireside chat at the 3rd Annual Evercore ISI Health CONx Conference on 3 December, 2020 from 08.00 – 8.20 am ET.

A live audio webcast of the fireside chat will be available on the events section of Freeline’s website.  An archived replay will be available on the Company’s website for a period of 90 days after the conference.